Cargando…
Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions
BACKGROUND: Pseudomonas aeruginosa, an increasingly prevalent opportunistic pathogen, utilizes a type III secretion system for injection of toxins into host cells in order to initiate infection. A crucial component of this system is PcrV, which is essential for cytotoxicity and is found both within...
Autores principales: | Nanao, Max, Ricard-Blum, Sylvie, Di Guilmi, Anne Marie, Lemaire, David, Lascoux, David, Chabert, Jacqueline, Attree, Ina, Dessen, Andréa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270082/ https://www.ncbi.nlm.nih.gov/pubmed/14565848 http://dx.doi.org/10.1186/1471-2180-3-21 |
Ejemplares similares
-
PcrG protects the two long helical oligomerization domains of PcrV, by an interaction mediated by the intramolecular coiled-coil region of PcrG
por: Basu, Abhishek, et al.
Publicado: (2014) -
Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
por: Wan, Chuang, et al.
Publicado: (2019) -
Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
por: Sundin, Charlotta, et al.
Publicado: (2021) -
Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
por: Faure, Karine, et al.
Publicado: (2003) -
Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023)